Adial Pharmaceuticals Inc (NASDAQ:ADIL)’s traded shares stood at 1.13 million during the latest session, with the company’s beta value hitting 1.21. At the last check today, the stock’s price was $0.68, to imply a decrease of -1.45% or -$0.01 in intraday trading. The ADIL share’s 52-week high remains $3.00, putting it -341.18% down since that peak but still an impressive 14.71% since price per share fell to its 52-week low of $0.58. The company has a valuation of $4.47M, with an average of 27930.0 shares in intraday trading volume over the past 10 days and average of 776.22K shares over the past 3 months.

Adial Pharmaceuticals Inc (NASDAQ:ADIL) trade information

After registering a -1.45% downside in the latest session, Adial Pharmaceuticals Inc (ADIL) has traded red over the past five days. The 5-day price performance for the stock is -4.90%, and 3.66% over 30 days. With these gigs, the year-to-date price performance is -32.67%. Short interest in Adial Pharmaceuticals Inc (NASDAQ:ADIL) saw shorts transact 0.22 million shares and set a 3.34 days time to cover.

An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 34.05% for the past 5-year period. While 2025 is set for a 27.94% return in earnings, projections for the next 5 years are at 41.31% annually.

ADIL Dividends

Adial Pharmaceuticals Inc has its next earnings report out on 2025-Mar-03. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Adial Pharmaceuticals Inc (NASDAQ:ADIL)’s Major holders

Adial Pharmaceuticals Inc insiders hold 1.40% of total outstanding shares, with institutional holders owning 9.37% of the shares at 9.50% float percentage. In total, 9.37% institutions holds shares in the company.

We also have Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Adial Pharmaceuticals Inc (ADIL) shares. Going by data provided on Feb 28, 2025 , Fidelity Concord Street Trust-Fidelity Extended Market Index Fund holds roughly 33.9 shares. This is just over 0.52% of the total shares, with a market valuation of $23086.0. Data from the same date shows that the other fund manager holds a little less at 9.36, or 0.14% of the shares, all valued at about 6374.0.